Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Eva S Schernhammer, M.D.

Title
Institution
Department
Address
Phone
Profile Picture
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21OH011052 (SCHERNHAMMER, EVA S) Sep 1, 2016 - Aug 31, 2018
    CDC/NIOSH
    Novel Circadian Exposure Metrics for Shift Workers
    Role: Principal Investigator
  2. R21MH101407 (SCHERNHAMMER, EVA S) May 1, 2014 - Apr 30, 2016
    NIH/NIMH
    Fetal Photoperiodic Programming and Affective Disorders in Adulthood
    Role: Principal Investigator
  3. R01OH009803 (SCHERNHAMMER, EVA S) Aug 1, 2010 - Aug 31, 2019
    CDC/NIOSH
    Adverse health effects of shift work
    Role: Principal Investigator
  4. R01AG030089 (SCHERNHAMMER, EVA S) Aug 1, 2008 - Jun 30, 2014
    NIH/NIA
    The Interplay Between Sleep, Melatonin, and Mortality in Older Men
    Role: Principal Investigator
  5. R03CA130054 (SCHERNHAMMER, EVA S) Sep 11, 2007 - Aug 31, 2010
    NIH/NCI
    Aspartame Intake and the Risk of Cancer
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Vetter C, Chang SC, Devore EE, Rohrer F, Okereke OI, Schernhammer ES. Prospective study of chronotype and incident depression among middle- and older-aged women in the Nurses' Health Study II. J Psychiatr Res. 2018 Aug; 103:156-160. PMID: 29860110.
    View in: PubMed
  2. Dhana K, Zong G, Yuan C, Schernhammer E, Zhang C, Wang X, Hu FB, Chavarro JE, Field AE, Sun Q. Lifestyle of women before pregnancy and the risk of offspring obesity during childhood through early adulthood. Int J Obes (Lond). 2018 Mar 03. PMID: 29568108.
    View in: PubMed
  3. Vetter C, Dashti HS, Lane JM, Anderson SG, Schernhammer ES, Rutter MK, Saxena R, Scheer FAJL. Night Shift Work, Genetic Risk, and Type 2 Diabetes in the UK Biobank. Diabetes Care. 2018 04; 41(4):762-769. PMID: 29440150.
    View in: PubMed
  4. Trudel-Fitzgerald C, Zhou ES, Poole EM, Zhang X, Michels KB, Eliassen AH, Chen WY, Holmes MD, Tworoger SS, Schernhammer ES. Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses' Health Study. Br J Cancer. 2018 Mar 20; 118(6):e6. PMID: 29315290.
    View in: PubMed
  5. Ramatowski JW, Lee CX, Mantzavino A, Ribas J, Guerra W, Preston ND, Schernhammer E, Madoff LC, Lassmann B. Planning an innovation marathon at an infectious disease conference with results from the International Meeting on Emerging Diseases and Surveillance 2016 Hackathon. Int J Infect Dis. 2017 Dec; 65:93-97. PMID: 29017856.
    View in: PubMed
  6. Wegrzyn LR, Tamimi RM, Rosner BA, Brown SB, Stevens RG, Eliassen AH, Laden F, Willett WC, Hankinson SE, Schernhammer ES. Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses' Health Studies. Am J Epidemiol. 2017 Sep 01; 186(5):532-540. PMID: 28541391.
    View in: PubMed
  7. James P, Bertrand KA, Hart JE, Schernhammer ES, Tamimi RM, Laden F. Outdoor Light at Night and Breast Cancer Incidence in the Nurses' Health Study II. Environ Health Perspect. 2017 08 17; 125(8):087010. PMID: 28886600.
    View in: PubMed
  8. Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Ellipse Consortium T, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Doherty JA, Gruber SB, Harrison TA, Hayes RB, Hoffmeister M, Houlston RS, Hung RJ, Jenkins MA, Kraft P, Lawrenson K, McKay J, Markt S, Mucci L, Phelan CM, Qu C, Risch A, Rossing MA, Wichmann HE, Shi J, Schernhammer E, Yu K, Landi MT, Caporaso NE. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Int J Cancer. 2017 11 01; 141(9):1794-1802. PMID: 28699174.
    View in: PubMed
  9. Huang T, Poole EM, Vetter C, Rexrode KM, Kubzansky LD, Schernhammer E, Rohleder N, Hu FB, Redline S, Tworoger SS. Habitual sleep quality and diurnal rhythms of salivary cortisol and dehydroepiandrosterone in postmenopausal women. Psychoneuroendocrinology. 2017 Oct; 84:172-180. PMID: 28738312.
    View in: PubMed
  10. Mischlinger J, Schernhammer E. A common trap of diagnostic tests : Disease prevalence and positive predictive value. Wien Klin Wochenschr. 2017 08; 129(15-16):583-584. PMID: 28447272.
    View in: PubMed
  11. Schernhammer ES. RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies. J Natl Cancer Inst. 2017 04 01; 109(4). PMID: 28376171.
    View in: PubMed
  12. Trudel-Fitzgerald C, Zhou ES, Poole EM, Zhang X, Michels KB, Eliassen AH, Chen WY, Holmes MD, Tworoger SS, Schernhammer ES. Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses' Health Study. Br J Cancer. 2017 04 25; 116(9):1239-1246. PMID: 28359077.
    View in: PubMed
  13. Devore EE, Massa J, Papantoniou K, Schernhammer ES, Wu K, Zhang X, Willett WC, Fuchs CS, Chan AT, Ogino S, Giovannucci E, Wei EK. Rotating night shift work, sleep, and colorectal adenoma in women. Int J Colorectal Dis. 2017 Jul; 32(7):1013-1018. PMID: 28097381.
    View in: PubMed
  14. Devore EE, Warner ET, Eliassen AH, Brown SB, Beck AH, Hankinson SE, Schernhammer ES. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):413-419. PMID: 28151704.
    View in: PubMed
  15. Fujishiro K, Lividoti Hibert E, Schernhammer E, Rich-Edwards JW. Shift work, job strain and changes in the body mass index among women: a prospective study. Occup Environ Med. 2017 06; 74(6):410-416. PMID: 27815430.
    View in: PubMed
  16. McMullan CJ, Rimm EB, Schernhammer ES, Forman JP. A nested case-control study of the association between melatonin secretion and incident myocardial infarction. Heart. 2017 05; 103(9):694-701. PMID: 27806988.
    View in: PubMed
  17. Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT, Bandera EV, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Aben KK, Anton-Culver H, Antonenkova N, Baker H, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, Dürst M, Easton D, Eccles D, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hogdall C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney LA, Klapdor R, Kolomeyevskaya N, Krakstad C, Kjaer SK, Kruszka B, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L, Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Pelttari LM, Perkins B, Permuth-Wey J, Pike MC, Plisiecka-Halasa J, Poole EM, Risch HA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schmitt K, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Tangen IL, Teo SH, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, Tyrer J, van Altena AM, Vergote I, Vierkant RA, Walsh C, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Gayther SA, Ramus SJ, Sellers TA, Schildkraut JM, Phelan CM, Berchuck A, Chenevix-Trench G, Cunningham JM, Pharoah PP, Ness RB, Odunsi K, Goode EL, Moysich KB. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016 10 25; 7(43):69097-69110. PMID: 27533245.
    View in: PubMed
  18. Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open. 2016; 1(5):e000097. PMID: 27843641.
    View in: PubMed
  19. Heckman CJ, Kloss JD, Feskanich D, Culnan E, Schernhammer ES. Associations among rotating night shift work, sleep and skin cancer in Nurses' Health Study II participants. Occup Environ Med. 2017 03; 74(3):169-175. PMID: 27663986.
    View in: PubMed
  20. Papantoniou K, Vetter C, Schernhammer ES. Shift work practices and opportunities for intervention. Occup Environ Med. 2017 01; 74(1):2-3. PMID: 27629936.
    View in: PubMed
  21. Devore EE, Harrison SL, Stone KL, Holton KF, Barrett-Connor E, Ancoli-Israel S, Yaffe K, Ensrud K, Cawthon PM, Redline S, Orwoll E, Schernhammer ES. Association of urinary melatonin levels and aging-related outcomes in older men. Sleep Med. 2016 07; 23:73-80. PMID: 27692280.
    View in: PubMed
  22. Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men. J Biol Rhythms. 2016 10; 31(5):461-9. PMID: 27449477.
    View in: PubMed
  23. Goswami U, Ensrud KE, Paudel ML, Redline S, Schernhammer ES, Shikany JM, Stone KL, Kunisaki KM. Vitamin D Concentrations and Obstructive Sleep Apnea in a Multicenter Cohort of Older Males. Ann Am Thorac Soc. 2016 05; 13(5):712-8. PMID: 26845389.
    View in: PubMed
  24. Vetter C, Devore EE, Wegrzyn LR, Massa J, Speizer FE, Kawachi I, Rosner B, Stampfer MJ, Schernhammer ES. Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women. JAMA. 2016 Apr 26; 315(16):1726-34. PMID: 27115377.
    View in: PubMed
  25. Li Y, Gao X, Winkelman JW, Cespedes EM, Jackson CL, Walters AS, Schernhammer E, Redline S, Hu FB. Association between sleeping difficulty and type 2 diabetes in women. Diabetologia. 2016 Apr; 59(4):719-27. PMID: 26818148.
    View in: PubMed
  26. Devore EE, Grodstein F, Schernhammer ES. Sleep Duration in Relation to Cognitive Function among Older Adults: A Systematic Review of Observational Studies. Neuroepidemiology. 2016; 46(1):57-78. PMID: 26735553.
    View in: PubMed
  27. Wermuth L, Cui X, Greene N, Schernhammer E, Ritz B. Medical Record Review to Differentiate between Idiopathic Parkinson's Disease and Parkinsonism: A Danish Record Linkage Study with 10 Years of Follow-Up. Parkinsons Dis. 2015; 2015:781479. PMID: 26770868; PMCID: PMC4681800.
  28. Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chen Z, Chen YA, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Dicks E, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Jim H, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant RA, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Kelemen LE, Berchuck A, Schildkraut JM, Ramus SJ, Goode EL, Monteiro AN, Gayther SA, Narod SA, Pharoah PD, Sellers TA, Phelan CM. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol. 2015 Dec; 39(8):689-97. PMID: 26399219.
    View in: PubMed
  29. Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Sieh W, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Vierkant RA, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Thomsen L, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Palmieri Weber R, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Schernhammer E, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Teo SH, Terry KL, Thompson PJ, Tangen IL, Tworoger SS, van Altena AM, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Amankwah E, Berchuck A, Schildkraut JM, Kelemen LE, Ramus SJ, Monteiro AN, Goode EL, Narod SA, Gayther SA, Pharoah PD, Sellers TA, Phelan CM. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res. 2015; 2(2). PMID: 26807442.
    View in: PubMed
  30. Saksvik-Lehouillier I, Harrison SL, Marshall LM, Tranah GJ, Ensrud K, Ancoli-Israel S, Clemons A, Redline S, Stone KL, Schernhammer ES. Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study. J Gerontol A Biol Sci Med Sci. 2015 Dec; 70(12):1569-77. PMID: 26265731; PMCID: PMC4723659 [Available on 12/01/16].
  31. Gaskins AJ, Rich-Edwards JW, Lawson CC, Schernhammer ES, Missmer SA, Chavarro JE. Work schedule and physical factors in relation to fecundity in nurses. Occup Environ Med. 2015 Nov; 72(11):777-83. PMID: 26251064; PMCID: PMC4609294 [Available on 10/01/16].
  32. Poole EM, Schernhammer E, Mills L, Hankinson SE, Tworoger SS. Urinary melatonin and risk of ovarian cancer. Cancer Causes Control. 2015 Oct; 26(10):1501-6. PMID: 26223889; PMCID: PMC4567911 [Available on 10/01/16].
  33. Hersh C, Sisti J, Richiutti V, Schernhammer E. The effects of sleep and light at night on melatonin in adolescents. Hormones (Athens). 2015 Jul-Sep; 14(3):399-409. PMID: 26233931.
    View in: PubMed
  34. Mu F, Hankinson SE, Schernhammer E, Pollak MN, Missmer SA. A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis. Am J Epidemiol. 2015 Jul 15; 182(2):148-56. PMID: 26121987; PMCID: PMC4493981.
  35. Vetter C, Devore EE, Ramin CA, Speizer FE, Willett WC, Schernhammer ES. Mismatch of Sleep and Work Timing and Risk of Type 2 Diabetes. Diabetes Care. 2015 Sep; 38(9):1707-13. PMID: 26109502; PMCID: PMC4542269.
  36. Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Dicks E, Doherty JA, Dörk T, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kelemen LE, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston L, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant RA, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Hasmad HN, Berchuck A, Iversen ES, Schildkraut JM, Ramus SJ, Goode EL, Monteiro AN, Gayther SA, Narod SA, Pharoah PD, Sellers TA, Phelan CM. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One. 2015; 10(6):e0128106. PMID: 26091520; PMCID: PMC4474865.
  37. Schernhammer ES, Lassen CF, Kenborg L, Ritz B, Olsen JH, Hansen J. Occupational history of night shift work and Parkinson's disease in Denmark. Scand J Work Environ Health. 2015 Jul; 41(4):377-83. PMID: 25950750.
    View in: PubMed
  38. Ramin CA, Massa J, Wegrzyn LR, Brown SB, Pierre-Paul J, Devore EE, Hankinson SE, Schernhammer ES. The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers. BMC Public Health. 2015 May 06; 15:467. PMID: 25943349; PMCID: PMC4424517.
  39. Kenborg L, Lassen CF, Ritz B, Andersen KK, Christensen J, Schernhammer ES, Hansen J, Wermuth L, Rod NH, Olsen JH. Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study. Am J Epidemiol. 2015 May 15; 181(10):808-16. PMID: 25925389; PMCID: PMC4423523.
  40. Pearce N, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli AA, Beland FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW, Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS, Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M, Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M, Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P, LeMasters G, Lubin JH, Lynch CF, Lynge E, 't Mannetje A, McMichael AJ, McLaughlin JR, Marrett L, Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer FE, Monson R, Nordby KC, Olshan AF, Parent ME, Perera FP, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S, Schernhammer E, Costantini AS, Seixas N, Shy C, Siemiatycki J, Silverman DT, Simonato L, Smith AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart PA, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg CR, Weisenburger D, Wesseling C, Weiderpass E, Zahm SH. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect. 2015 Jun; 123(6):507-14. PMID: 25712798; PMCID: PMC4455595.
  41. Devore EE, Kim S, Ramin CA, Wegrzyn LR, Massa J, Holmes MD, Michels KB, Tamimi RM, Forman JP, Schernhammer ES. Antihypertensive medication use and incident breast cancer in women. Breast Cancer Res Treat. 2015 Feb; 150(1):219-29. PMID: 25701121; PMCID: PMC4381798.
  42. Massa J, Stone KL, Wei EK, Harrison SL, Barrett-Connor E, Lane NE, Paudel M, Redline S, Ancoli-Israel S, Orwoll E, Schernhammer E. Vitamin D and actigraphic sleep outcomes in older community-dwelling men: the MrOS sleep study. Sleep. 2015 Feb 01; 38(2):251-7. PMID: 25581929; PMCID: PMC4288606.
  43. Lawson CC, Johnson CY, Chavarro JE, Lividoti Hibert EN, Whelan EA, Rocheleau CM, Grajewski B, Schernhammer ES, Rich-Edwards JW. Work schedule and physically demanding work in relation to menstrual function: the Nurses' Health Study 3. Scand J Work Environ Health. 2015 Mar; 41(2):194-203. PMID: 25634477.
    View in: PubMed
  44. Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, Willett WC, Schernhammer ES. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II. Am J Epidemiol. 2015 Feb 01; 181(3):155-62. PMID: 25587174; PMCID: PMC4312424.
  45. Gu F, Han J, Laden F, Pan A, Caporaso NE, Stampfer MJ, Kawachi I, Rexrode KM, Willett WC, Hankinson SE, Speizer FE, Schernhammer ES. Total and cause-specific mortality of U.S. nurses working rotating night shifts. Am J Prev Med. 2015 Mar; 48(3):241-52. PMID: 25576495.
    View in: PubMed
  46. Vetter C, Schernhammer ES. Early, but not late chronotypes, are up during their biological night when working the night shift. Occup Environ Med. 2015 Mar; 72(3):235. PMID: 25510823.
    View in: PubMed
  47. Nishihara R, Wang M, Qian ZR, Baba Y, Yamauchi M, Mima K, Sukawa Y, Kim SA, Inamura K, Zhang X, Wu K, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Schernhammer ES. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. Am J Clin Nutr. 2014 Dec; 100(6):1479-88. PMID: 25411283; PMCID: PMC4232016.
  48. Ramin C, Devore EE, Wang W, Pierre-Paul J, Wegrzyn LR, Schernhammer ES. Night shift work at specific age ranges and chronic disease risk factors. Occup Environ Med. 2015 Feb; 72(2):100-7. PMID: 25261528; PMCID: PMC4289641.
  49. Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol. 2015 Feb; 67(2):191-4. PMID: 25107635.
    View in: PubMed
  50. Lawson C, Johnson C, Chavarro J, Lividoti Hibert E, Whelan E, Rocheleau C, Grajewski B, Schernhammer E, Rich-Edwards J. 0119 Shift work, long working hours, and physical labour in relation to menstrual function: the Nurses' Health Study 3. Occup Environ Med. 2014 Jun; 71 Suppl 1:A13. PMID: 25018257.
    View in: PubMed
  51. Schernhammer E. 0359 Nighshift work and breast cancer risk - good news, bad news ? Occup Environ Med. 2014 Jun; 71 Suppl 1:A121. PMID: 25018242.
    View in: PubMed
  52. Devore EE, Grodstein F, Duffy JF, Stampfer MJ, Czeisler CA, Schernhammer ES. Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc. 2014 Jun; 62(6):1073-81. PMID: 24786726; PMCID: PMC4188530.
  53. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Richter JM, Schernhammer ES, Chan AT. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1879-86. PMID: 24780288.
    View in: PubMed
  54. Chen WY, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Schernhammer ES. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 2014 Jun; 145(2):381-8. PMID: 24718775; PMCID: PMC4060962.
  55. Bajaj A, Stone KL, Peters K, Parimi N, Barrett-Connor E, Bauer D, Cawthon PM, Ensrud KE, Hoffman AR, Orwoll E, Schernhammer ES. Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. J Clin Endocrinol Metab. 2014 Sep; 99(9):3256-62. PMID: 24670083; PMCID: PMC4154079.
  56. Nielsen M, Hansen J, Ritz B, Nordahl H, Schernhammer E, Wermuth L, Rod NH. Cause-specific mortality among spouses of Parkinson disease patients. Epidemiology. 2014 Mar; 25(2):225-32. PMID: 24378369.
    View in: PubMed
  57. Devore EE, Grodstein F, Schernhammer ES. Shift work and cognition in the Nurses' Health Study. Am J Epidemiol. 2013 Oct 15; 178(8):1296-300. PMID: 24076971; PMCID: PMC3792735.
  58. Stevens RG, Hansen J, Schernhammer ES, Davis S. Response to Ijaz S, et al. "Night-shift work and breast cancer--a systematic review and meta-analysis". Scand J Work Environ Health. 2013 Nov; 39(6):631-2. PMID: 24065167.
    View in: PubMed
  59. Schernhammer ES, Feskanich D, Liang G, Han J. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol. 2013 Nov 01; 178(9):1434-41. PMID: 24049158; PMCID: PMC3813313.
  60. Ramin C, Devore EE, Pierre-Paul J, Duffy JF, Hankinson SE, Schernhammer ES. Chronotype and breast cancer risk in a cohort of US nurses. Chronobiol Int. 2013 Nov; 30(9):1181-6. PMID: 23961712; PMCID: PMC4007068.
  61. McMullan CJ, Schernhammer ES, Forman JP. Melatonin level and risk for type 2 diabetes--in reply. JAMA. 2013 Aug 07; 310(5):537. PMID: 23925631.
    View in: PubMed
  62. McMullan CJ, Curhan GC, Schernhammer ES, Forman JP. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013 Jul 15; 178(2):231-8. PMID: 23813704; PMCID: PMC3937598.
  63. Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, Krogh V, Abbagnato C, Grioni S, Blandino G, Schunemann HJ, Muti P. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Res. 2013 Jun 18; 15(3):R46. PMID: 23777922; PMCID: PMC4053232.
  64. Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):872-9. PMID: 23652374.
    View in: PubMed
  65. Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 2013 May 01; 36(5):681-8. PMID: 23633750; PMCID: PMC3624822.
  66. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013 Apr 03; 309(13):1388-96. PMID: 23549584; PMCID: PMC3804914.
  67. Schernhammer E, Qiu J, Wermuth L, Lassen CF, Friis S, Ritz B. Gout and the risk of Parkinson's disease in Denmark. Eur J Epidemiol. 2013 Apr; 28(4):359-60. PMID: 23456139; PMCID: PMC3655156.
  68. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84. PMID: 23307060; PMCID: PMC3637979.
  69. Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T, Yamauchi M, Liao X, Qian ZR, Sun R, Sato K, Kirkner GJ, Wang M, Spiegelman D, Meyerhardt JA, Schernhammer ES, Chan AT, Giovannucci E, Fuchs CS. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst. 2013 Jan 16; 105(2):130-40. PMID: 23175808; PMCID: PMC3545905.
  70. Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012 Dec; 96(6):1419-28. PMID: 23097267; PMCID: PMC3497928.
  71. Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 2012 Dec 01; 131(11):2547-52. PMID: 22473669; PMCID: PMC3408553.
  72. Li WQ, Qureshi AA, Schernhammer ES, Han J. Rotating night-shift work and risk of psoriasis in US women. J Invest Dermatol. 2013 Feb; 133(2):565-7. PMID: 22931920; PMCID: PMC3511636.
  73. Thompson CA, Waldhör T, Schernhammer ES, Hackl M, Vutuc C, Haidinger G. Smoking and lung cancer: current trends in Austria. Wien Klin Wochenschr. 2012 Aug; 124(15-16):493-9. PMID: 22815002; PMCID: PMC3782091.
  74. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1002-11. PMID: 22564869; PMCID: PMC3392423.
  75. Schernhammer ES, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Chen WY. A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. Cancer Causes Control. 2012 Apr; 23(4):609-16. PMID: 22370698.
    View in: PubMed
  76. Bonde JP, Hansen J, Kolstad HA, Mikkelsen S, Olsen JH, Blask DE, Härmä M, Kjuus H, de Koning HJ, Olsen J, Møller M, Schernhammer ES, Stevens RG, Åkerstedt T. Work at night and breast cancer--report on evidence-based options for preventive actions. Scand J Work Environ Health. 2012 Jul; 38(4):380-90. PMID: 22349009.
    View in: PubMed
  77. Sigurdardottir L, Valdimarsdottir UA, Mucci L, Fall K, Rider JR, Schernhammer ES, Czeisler CA, Launer L, Harris TB, Stampfer MJ, Gudnason V, Lockley SW. Insomnia among elderly men and risk of prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):78. PMID: 28142941.
    View in: PubMed
  78. Lieu SJ, Curhan GC, Schernhammer ES, Forman JP. Rotating night shift work and disparate hypertension risk in African-Americans. J Hypertens. 2012 Jan; 30(1):61-6. PMID: 22134389.
    View in: PubMed
  79. Pan A, Schernhammer ES, Sun Q, Hu FB. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011 Dec; 8(12):e1001141. PMID: 22162955; PMCID: PMC3232220.
  80. Liang G, Schernhammer E, Qi L, Gao X, De Vivo I, Han J. Associations between rotating night shifts, sleep duration, and telomere length in women. PLoS One. 2011; 6(8):e23462. PMID: 21853136; PMCID: PMC3154494.
  81. Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol. 2011 Sep 15; 174(6):642-51. PMID: 21828371; PMCID: PMC3166705.
  82. Bajaj A, Rosner B, Lockley SW, Schernhammer ES. Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20(7):1341-9. PMID: 21737411; PMCID: PMC3340010.
  83. Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PLoS One. 2011; 6(6):e21102. PMID: 21738611; PMCID: PMC3124479.
  84. Schernhammer ES, Vitonis AF, Rich-Edwards J, Missmer SA. Rotating nightshift work and the risk of endometriosis in premenopausal women. Am J Obstet Gynecol. 2011 Nov; 205(5):476.e1-8. PMID: 21907958; PMCID: PMC3205317.
  85. Schernhammer ES, Stone KL. Light pollution???light pollution? Chronobiol Int. 2011 May; 28(4):378-9; author reply 379-80. PMID: 21539430.
    View in: PubMed
  86. Lawson CC, Whelan EA, Lividoti Hibert EN, Spiegelman D, Schernhammer ES, Rich-Edwards JW. Rotating shift work and menstrual cycle characteristics. Epidemiology. 2011 May; 22(3):305-12. PMID: 21364464.
    View in: PubMed
  87. Manthripragada AD, Schernhammer ES, Qiu J, Friis S, Wermuth L, Olsen JH, Ritz B. Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease. Neuroepidemiology. 2011; 36(3):155-61. PMID: 21508649; PMCID: PMC3095838.
  88. Poole EM, Schernhammer ES, Tworoger SS. Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):934-8. PMID: 21467237; PMCID: PMC3089706.
  89. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care. 2011 May; 34(5):1102-8. PMID: 21411503; PMCID: PMC3114482.
  90. Schernhammer ES, Razavi P, Li TY, Qureshi AA, Han J. Rotating night shifts and risk of skin cancer in the nurses' health study. J Natl Cancer Inst. 2011 Apr 06; 103(7):602-6. PMID: 21335547; PMCID: PMC3071354.
  91. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, Kogevinas M, Kogi K, Lie JA, Lowden A, Peplonska B, Pesch B, Pukkala E, Schernhammer E, Travis RC, Vermeulen R, Zheng T, Cogliano V, Straif K. Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med. 2011 Feb; 68(2):154-62. PMID: 20962033.
    View in: PubMed
  92. Schernhammer ES, Thompson CA. Light at night and health: the perils of rotating shift work. Occup Environ Med. 2011 May; 68(5):310-1. PMID: 20921271.
    View in: PubMed
  93. Kenborg L, Lassen CF, Ritz B, Schernhammer ES, Hansen J, Gatto NM, Olsen JH. Outdoor work and risk for Parkinson's disease: a population-based case-control study. Occup Environ Med. 2011 Apr; 68(4):273-8. PMID: 20884793; PMCID: PMC3667158.
  94. Rod NH, Hansen J, Schernhammer E, Ritz B. Major life events and risk of Parkinson's disease. Mov Disord. 2010 Aug 15; 25(11):1639-45. PMID: 20602449; PMCID: PMC2928859.
  95. Ritz B, Manthripragada AD, Qian L, Schernhammer E, Wermuth L, Olsen J, Friis S. Statin use and Parkinson's disease in Denmark. Mov Disord. 2010 Jul 15; 25(9):1210-6. PMID: 20629142; PMCID: PMC2910157.
  96. Bajaj A, Schernhammer ES, Haidinger G, Waldhör T. Trends in mortality from stroke in Austria, 1980-2008. Wien Klin Wochenschr. 2010 Jun; 122(11-12):346-53. PMID: 20559879.
    View in: PubMed
  97. Schernhammer E, Haidinger G, Waldhör T, Vargas R, Vutuc C. A study of trends in beliefs and attitudes toward cancer. J Cancer Educ. 2010 Jun; 25(2):211-6. PMID: 20432076.
    View in: PubMed
  98. Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS, Ogino S. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010 May 27; 9:125. PMID: 20507599; PMCID: PMC2892454.
  99. Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol. 2010 May; 67(5):600-6. PMID: 20437557; PMCID: PMC2917467.
  100. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):729-37. PMID: 20200429; PMCID: PMC2837369.
  101. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010 Mar; 28(3):446-51. PMID: 20090558; PMCID: PMC2923437.
  102. Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, Hazra A, Schernhammer ES, Hunter DJ, Fuchs CS, Ogino S. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn. 2010 Mar; 12(2):177-83. PMID: 20093385; PMCID: PMC2871724.
  103. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010 May; 21(5):697-707. PMID: 20054708.
    View in: PubMed
  104. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010 Jun; 59(6):794-9. PMID: 19828464; PMCID: PMC2895465.
  105. Schernhammer ES, Haidinger G, Waldhör T, Vutuc C. Attitudes about the use of complementary and alternative medicine in cancer treatment. J Altern Complement Med. 2009 Oct; 15(10):1115-20. PMID: 19848548.
    View in: PubMed
  106. Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH. Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology. 2009 Nov 03; 73(18):1462-8. PMID: 19776374; PMCID: PMC2779008.
  107. Schernhammer ES, Feskanich D, Niu C, Dopfel R, Holmes MD, Hankinson SE. Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts. Am J Clin Nutr. 2009 Oct; 90(4):975-85. PMID: 19675108; PMCID: PMC2744623.
  108. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009 Nov; 20(9):1753-6. PMID: 19649715.
    View in: PubMed
  109. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Effect of light perception on menarche in blind women. Ophthalmic Epidemiol. 2009 Jul-Aug; 16(4):243-8. PMID: 19874146.
    View in: PubMed
  110. Brown DL, Feskanich D, Sánchez BN, Rexrode KM, Schernhammer ES, Lisabeth LD. Rotating night shift work and the risk of ischemic stroke. Am J Epidemiol. 2009 Jun 01; 169(11):1370-7. PMID: 19357324; PMCID: PMC2727250.
  111. Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):74-9. PMID: 19124483; PMCID: PMC3036562.
  112. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 2009 Aug 18; 281(1):1-7. PMID: 19070424; PMCID: PMC2735793.
  113. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst. 2008 Dec 03; 100(23):1734-8. PMID: 19033568; PMCID: PMC2639290.
  114. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008; 3(11):e3698. PMID: 19002263; PMCID: PMC2579485.
  115. Schernhammer ES, Giovannuccci E, Fuchs CS, Ogino S. A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2895-8. PMID: 18843035; PMCID: PMC2741404.
  116. Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses' Health Study. Osteoporos Int. 2009 Apr; 20(4):537-42. PMID: 18766292; PMCID: PMC2651998.
  117. Schernhammer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008 Sep; 135(3):770-80. PMID: 18619459; PMCID: PMC2634965.
  118. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2008 Jun 18; 100(12):898-905. PMID: 18544743; PMCID: PMC2630389.
  119. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res. 2008 Apr 01; 68(7):2507-13. PMID: 18381460; PMCID: PMC2857531.
  120. IARC, Monograph Working Group [Member]. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 98. Fire-fighting, painting, and nightshift work. Lyon: International Agency for Research on Cancer. 2008.
  121. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Dynamics of the Prevalence of Atopic Disease in Austrian Children. Pediatr Allergy Immunol. 2008; 19(2):125-31.
  122. Moser M, Schernhammer E, Stevens R [editors]. “Rhythm and Cancer”. 2008.
  123. Schernhammer ES, Ogino S, Fuchs C. Folate and vitamin B6 intake and colon cancer in relation to p53 mutational status. Gastroenterology. 2008; 135(3):770-780.
  124. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley, SW. Effect of light perception on menarche in blind women. Human Reproduction. 2008; (under review).
  125. Schernhammer ES, Waldhör T, Haidinger G, Vargas RB, Vutuc C. A study of trends in beliefs and attitudes toward cancer in Austria. J Cancer Edu. 2008; (under review).
  126. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol. 2008 Mar; 19(2):125-31. PMID: 18086231.
    View in: PubMed
  127. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007 Nov 01; 67(21):10618-22. PMID: 17975006.
    View in: PubMed
  128. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008 Jan; 134(1):21-8. PMID: 18005960; PMCID: PMC2719297.
  129. Megdal SP, Schernhammer ES. Correlates for poor sleepers in a Los Angeles high school. Sleep Med. 2007 Dec; 9(1):60-3. PMID: 17869576.
    View in: PubMed
  130. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer. 2007 Sep; 14(3):721-32. PMID: 17914102.
    View in: PubMed
  131. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res. 2007 Aug 15; 67(16):7923-8. PMID: 17699799.
    View in: PubMed
  132. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007 Jun 01; 67(11):5553-60. PMID: 17545639.
    View in: PubMed
  133. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer. 2007 Jul 02; 97(1):98-104. PMID: 17533398; PMCID: PMC2359655.
  134. Dopfel RP, Schulmeister K, Schernhammer ES. Nutritional and lifestyle correlates of the cancer-protective hormone melatonin. Cancer Detect Prev. 2007; 31(2):140-8. PMID: 17418976.
    View in: PubMed
  135. Schernhammer ES, Tworoger SS, Eliassen HA, Missmer SA, Holly J, Pollak MN, Hankinson SE. Body shape throughout life and correlations with insulin-like growth factors and growth hormone. Endocr Rel Cancer. 2007; 14(3):723-734.
  136. Straif K, Baan R, Grosse Y, Secretan B, Ghissassi FE, Bouvard V, Altieri A, Benbrahim-Ballaa L, Cogliano V, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8(12):1065-66.
  137. Schernhammer ES. Melatonin and Cancer [invited book chapter]. ‘Melatonin: From Molecules to Therapy’. S.R. Pandi-Perumal, Editor. 2007.
  138. Rea M, Biermann A, Figueiro M, Zhou Y, Schernhammer E. Light and Dark Activity and Rest in Dayshift and Nightshift Nurses. Pro Society for Light Treatment and Biological Rhythms (SLTBR) 19th Annual Meeting, Copenhagen, Denmark, 2007. Chronobiology International 2008. 2007.
  139. Kroenke CH, Spiegelman D, Manson J, Schernhammer ES, Colditz GA, Kawachi I. Work characteristics and incidence of type 2 diabetes in women. Am J Epidemiol. 2007 Jan 15; 165(2):175-83. PMID: 17071844.
    View in: PubMed
  140. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer. 2006 Jun; 13(2):583-92. PMID: 16728584.
    View in: PubMed
  141. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 2006 May 15; 66(10):5521-5. PMID: 16707482.
    View in: PubMed
  142. Schernhammer E, Chen H, Ritz B. Circulating melatonin levels: possible link between Parkinson's disease and cancer risk? Cancer Causes Control. 2006 May; 17(4):577-82. PMID: 16596313.
    View in: PubMed
  143. Moser M, Schaumberger K, Schernhammer E, Stevens RG. Cancer and rhythm. Cancer Causes Control. 2006 May; 17(4):483-7. PMID: 16596301.
    View in: PubMed
  144. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer. 2006 Mar 27; 94(6):928-34. PMID: 16495921; PMCID: PMC2361367.
  145. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res. 2006 Mar; 40(2):116-24. PMID: 16441548.
    View in: PubMed
  146. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol. 2006 Mar 01; 24(7):1105-11. PMID: 16505430.
    View in: PubMed
  147. Chen H, Schernhammer E, Schwarzschild MA, Ascherio A. A prospective study of night shift work, sleep duration, and risk of Parkinson's disease. Am J Epidemiol. 2006 Apr 15; 163(8):726-30. PMID: 16495472.
    View in: PubMed
  148. Tworoger SS, Lee S, Schernhammer ES, Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord. 2006 Jan-Mar; 20(1):41-8. PMID: 16493235.
    View in: PubMed
  149. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Willett WC, Fuchs CS. A Cyclin D A870G polymorphism and risk of colorectal adenomas as well as colorectal cancer in the Harvard cohorts. Br J Cancer. 2006; 94(6):928-34.
  150. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels K. Habitual duration of sleep and risk of breast cancer. Cancer Res. 2006; 66(10):5521-25.
  151. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006 Jan; 17(1):108-11. PMID: 16357603.
    View in: PubMed
  152. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses' Health Study II. Endocr Rel Cancer. 2006; 13:583-92.
  153. Moser M, Schaumberger K, Schernhammer ES, Stevens RG. Cancer and Rhythm [Editorial]. Cancer Causes Control. 2006; 17(4):483-87.
  154. Schernhammer E, Enzinger P. Insulin-like growth factor receptor (IGFR-I) as a target for future therapeutic interventions [invited book chapter]. ‘Signaltransduktion in der Onkologie – Grundlagen und therapeutische Möglichkeiten’ [German]. UNI-MED Science Verlag. Hsgb. Dittrich C. 2006; 13:101-18.
  155. Schernhammer ES, Kroenke C, Dowsett M, Folkerd E, Hankinson SE. Life-style factors, steroid hormone levels, and correlations with urinary 6-sulphatoxy melatonin levels. J Pineal Res. 2006; 40(2):116-124.
  156. Kroenke CH, Bennett GG, Fuchs C, Giovannucci E, Kawachi I, Schernhammer E, Holmes MD, Kubzansky LD. Depressive symptoms and prospective incidence of colorectal cancer in women. Am J Epidemiol. 2005 Nov 01; 162(9):839-48. PMID: 16207809.
    View in: PubMed
  157. Schernhammer ES, Hu FB, Giovannucci E, Michaud DS, Colditz GA, Stampfer MJ, Fuchs CS. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev. 2005 Sep; 14(9):2098-105. PMID: 16172216.
    View in: PubMed
  158. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005 Sep; 41(13):2023-32. PMID: 16084719.
    View in: PubMed
  159. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005 Aug 24; 294(8):914-23. PMID: 16118381; PMCID: PMC1550973.
  160. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005 Jul 20; 97(14):1084-7. PMID: 16030307.
    View in: PubMed
  161. Vutuc C, Schernhammer ES, Haidinger G, Waldhör T. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Wien Klin Wochenschr. 2005 Jul; 117(13-14):457-61. PMID: 16091872.
    View in: PubMed
  162. Schernhammer E. Taking their own lives -- the high rate of physician suicide. N Engl J Med. 2005 Jun 16; 352(24):2473-6. PMID: 15958803.
    View in: PubMed
  163. Baur M, Schernhammer E, Gneist M, Sevelda P, Speiser P, Hudec M, Dittrich Ch. Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. Br J Cancer. 2005 Mar 28; 92(6):1019-25. PMID: 15756278; PMCID: PMC2361931.
  164. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):699-704. PMID: 15767352.
    View in: PubMed
  165. Stevens RG, Schernhammer E. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2005 Feb; 14(2):551; author reply 551. PMID: 15734989.
    View in: PubMed
  166. Baur M, Schernhammer E, Gneist M, Sevelda P, Speiser P, Hudec M, Dittrich C. Phase I/II Study of oral etoposide plus GM-CSF as second line chemotherapy in platinum pretreated patients with advanced ovarian cancer. Br J Cancer 2005. 2005; 92(6):1019-1025.
  167. Kroenke C, Kawachi I, Kubzansky L, Schernhammer E. Three authors and Dr. Kubzansky reply [Letter to the Editor]. Am J Epidemiol. 2005; 162(11):1134-35.
  168. Schernhammer ES, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry. 2004 Dec; 161(12):2295-302. PMID: 15569903.
    View in: PubMed
  169. Schernhammer ES, Hankinson SE, Rosner B, Kroenke CH, Willett WC, Colditz GA, Kawachi I. Job stress and breast cancer risk: the nurses' health study. Am J Epidemiol. 2004 Dec 01; 160(11):1079-86. PMID: 15561987.
    View in: PubMed
  170. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004 Jul; 4(7):505-18. PMID: 15229476.
    View in: PubMed
  171. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):936-43. PMID: 15184249.
    View in: PubMed
  172. Kroenke CH, Hankinson SE, Schernhammer ES, Colditz GA, Kawachi I, Holmes MD. Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence. Am J Epidemiol. 2004 Jun 01; 159(11):1019-27. PMID: 15155286.
    View in: PubMed
  173. Fridrich P, Eappen S, Jaeger W, Schernhammer E, Zizza AM, Wang GK, Gerner P. Phase Ia and Ib study of amitriptyline for ulnar nerve block in humans: side effects and efficacy. Anesthesiology. 2004 Jun; 100(6):1511-8. PMID: 15166572.
    View in: PubMed
  174. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep. 2004 May 01; 27(3):440-4. PMID: 15164896.
    View in: PubMed
  175. Schernhammer E, Schulmeister K. Light at night and cancer risk. Photochem Photobiol. 2004 Apr; 79(4):316-8. PMID: 15137506.
    View in: PubMed
  176. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer. 2004 Mar 08; 90(5):941-3. PMID: 14997186; PMCID: PMC2409637.
  177. Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med. 2004 Feb 03; 140(3):157-66. PMID: 14757613.
    View in: PubMed
  178. Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst. 2004 Jan 07; 96(1):22-8. PMID: 14709735.
    View in: PubMed
  179. Schernhammer ES, Hankinson SE, Rosner B, Kroenke C, Speizer FE, Willett WC, Colditz GA, Kawachi I. Job stress and risk of breast cancer: The Nurses’ Health Study. Am J Epidemiol. 2004; 160(11):1079-1086.
  180. Schernhammer ES, Schulmeister K. Light at night and cancer risk [invited review]. Photochem Photobiol. 2004; 79(4):316-18.
  181. Schernhammer ES, Schulmeister K. Epidemiology of light at night and cancer risk. 2004.
  182. Baur M, Schernhammer E, Sevelda P, Speiser P, Gneist M, Hudec M, Dittrich C. Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum pretreated patients with advanced ovarian cancer. Onkologie (Pro ‘Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsachaften für Hämatologie und Onkologie, Innsbruck, Austria). 2004; 27(Suppl 3):643.
  183. Schernhammer ES, Hunter DJ, Pollak M, Hankinson SE. A growth hormone polymorphism at position 1663 in intron 4 of the GH1 gene is not associated with breast cancer risk. Int J Cancer Prev. 2004; 1(1):33-37.
  184. Schernhammer ES. Harvard launches a workshop series targeting the control of obesity in the US. Cancer Causes Control. 2003 Dec; 14(10):1009-12. PMID: 14750541.
    View in: PubMed
  185. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN. Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer. 2003 Oct 20; 107(1):60-4. PMID: 12925957.
    View in: PubMed
  186. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003 Jun 04; 95(11):825-8. PMID: 12783938.
    View in: PubMed
  187. Schernhammer ES, Leitzmann MF, Michaud DS, Speizer FE, Giovannucci E, Colditz GA, Fuchs CS. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer. 2003 Jan 13; 88(1):79-83. PMID: 12556963; PMCID: PMC2376770.
  188. Schernhammer ES, Hankinson SE. Light at night: A novel risk factor for cancer in shift workers? [invited review]. Clinics in Occupational and Environmental Medicine/ Chronobiology and Shiftwork. 2003; 3(2):263-78.
  189. Schernhammer ES, Dittrich CH. Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors [invited review]. Wien Med Wochenschrift. 2003; 153(5-6):1-12.
  190. Schernhammer ES. Harvard launches a workshop series targeting the control of obesity in the U.S. Cancer Causes & Control. 2003; 14(10):1009-12.
  191. Schernhammer ES, Dittrich C. [Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]. Wien Med Wochenschr. 2003; 153(5-6):104-15. PMID: 12705063.
    View in: PubMed
  192. Hankinson SE, Schernhammer ES. Insulin-like growth factor and breast cancer risk: evidence from observational studies [invited review]. Breast Diseases. 2003; 17:27-40.
  193. Schernhammer ES, Hankinson SE. Epidemiologic approaches to evaluating IGF and cancer risk [invited book chapter]. Insulin-like Growth Factors. Landes Bioscience; LeRoith D, Zumkeller W, Baxter R, editors. 2003; Chapter 19:317-38 .
  194. Hankinson SE, Schernhammer ES. Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis. 2003; 17:27-40. PMID: 15687675.
    View in: PubMed
  195. Schernhammer ES. In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor? Cancer Causes Control. 2002 Aug; 13(6):505-8. PMID: 12195639.
    View in: PubMed
  196. Schernhammer ES, Michaud DS, Leitzmann MF, Giovannucci E, Colditz GA, Fuchs CS. Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer. 2002 Apr 08; 86(7):1081-4. PMID: 11953853; PMCID: PMC2364180.
  197. Schernhammer ES, Schulmeister K. Night Work and Cancer Risk. 2002.
  198. Schernhammer ES, Colditz GA. Response: Night shift work, light at night, and risk of breast cancer [editorial]. J Natl Cancer Inst. 2002; 94(7):530-1.
  199. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001 Oct 17; 93(20):1563-8. PMID: 11604480.
    View in: PubMed
  200. Kienzer H, Baur M, Faezeny M, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Point J, Dittrich C. Intra-individual dose escalation with carboplatin/mitomycin C in advanced breast cancer. Ann Oncol (Pro ESMO, Athens, Greece). 1998; 9(Suppl 4):125.
  201. Kienzer H, Schweiger J, Baur M, DeSantis M, Poehnl R, Gerber E, Soucek B, Schernhammer E, Postner G, Pont J, Schlappack A, Schratter-Sehn A, Wicke W, Dittrich CH. Docetaxel/cisplatin as first-line therapy in head and neck cancer. Pro ASCO. 1998; 17(1566).
  202. Baur M, Kienzer H, Schweiger J, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Pont J, Schratter-Sehn A, Wicke W, Dittrich CH. First-line therapy in head and neck cancer with docetaxel/cisplatin. Ann Oncol (Pro ESMO, Athens, Greece). 1998; 9(Suppl 4):362.
  203. Fazeny B, Stubenvoll R, DeSantis M, Poehnl R, Soucek B, Schernhammer E, Postner G, Kienzer H, Kraus R, Pont J, Dittrich CH. Carboplatin/mitomycin C (MMC) as salvage therapy with intraindividual dose escalation in advanced breast cancer. Pro ASCO, Los Angeles, CA. 1998; 17(489).
  204. Czejka M, Bandak S, Simon D, Schüller J, Weiss C, Schernhammer E. Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine. Z Naturforsch C. 1995 Jul-Aug; 50(7-8):565-70. PMID: 7546045.
    View in: PubMed
  205. Czejka M, Schüller J, Schernhammer E, Bandak S. [Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion]. Pharmazie. 1995 Jun; 50(6):416-9. PMID: 7651979.
    View in: PubMed
  206. Bandak S, Czejka M, Schüller J, Schernhammer E. Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells. Arzneimittelforschung. 1995 Feb; 45(2):212-5. PMID: 7710452.
    View in: PubMed
  207. Thürlimann B, Kröger N, Greiner J, Mross K, Schüller J, Schernhammer E, Schumacher K, Gastl G, Hartlapp J, Kupper H, et al. Dexverapamil to overcome epirubicin resistance in advanced breast cancer. J Cancer Res Clin Oncol. 1995; 121 Suppl 3:R3-6. PMID: 8698740.
    View in: PubMed
  208. Czejka M, Bandak S, Simon D, Schueller J, Weiss C, Schernhammer E. Pharmacokinetic interaction between 4’-epidoxorubicin and the multidrug resistance reverting agent quinine. Z Naturforschung. 1995; 50(7-8):565-70.
  209. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Serum and tissue levels of d- and 1- Methyltetrahydrofolic acid (MTHF) after i.v. bolus of (d,1) MTHF. Fruehjahrstagung der Oesterreichischen Gesellschaft fuer Haematologie und Onkologie, Wien. 1994.
  210. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Serum and tissue levels of d- and 1- Methyltetrahydrofolic acid (MTHF) after i.v. bolus of (d,1). MTHF, Pro AACR, San Francisco, CA. 1994; 35(2561).
  211. Schueller J, Czejka M, Bandak S, Wirth M, Schernhammer E, Schernthaner G. Epirubicin pharmacokinetics, influence of interferon alfa 2b in advanced cancer patients. Pro ASCO, Dallas, TX. 1994; 13(446).
  212. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Pharmacokinetics of racemic or L-Leucovorin in serum and red blood cells. Annual Congress of the German and the Austrian Society of Hematology and Oncology, Essen. Ann Hematol. 1993; 2993:67 (Suppl).
  213. Schueller J, Schernhammer E, Weiss C, Fogl U. Therapie von Karzinomschmerzen. 3. Wiener Dialog ueber Ganzheitsmedizin und Schmerz. 1993.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Schernhammer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (468)
Explore
_
Co-Authors (102)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_